These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25590655)

  • 1. Proof of concept study for designed multiple ligands targeting the dopamine D2, serotonin 5-HT2A, and muscarinic M1 acetylcholine receptors.
    Szabo M; Lim HD; Herenbrink CK; Christopoulos A; Lane JR; Capuano B
    J Med Chem; 2015 Feb; 58(3):1550-5. PubMed ID: 25590655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
    Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
    Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.
    Stefanowicz J; Słowiński T; Wróbel MZ; Herold F; Gomółka AE; Wesołowska A; Jastrzębska-Więsek M; Partyka A; Andres-Mach M; Czuczwar SJ; Łuszczki JJ; Zagaja M; Siwek A; Nowak G; Żołnierek M; Bączek T; Ulenberg S; Belka M; Turło J
    Bioorg Med Chem; 2016 Sep; 24(18):3994-4007. PubMed ID: 27377863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold.
    Deng X; Guo L; Xu L; Zhen X; Yu K; Zhao W; Fu W
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3970-4. PubMed ID: 26227779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.
    Carro L; Torrado M; Raviña E; Masaguer CF; Lage S; Brea J; Loza MI
    Eur J Med Chem; 2014 Jan; 71():237-49. PubMed ID: 24316025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New dual ligands for the D
    Zaręba P; Jaśkowska J; Śliwa P; Satała G
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2236-2242. PubMed ID: 31253532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-5-HT/D
    Żmudzki P; Satała G; Chłoń-Rzepa G; Bojarski AJ; Kazek G; Siwek A; Gryboś A; Głuch-Lutwin M; Wesołowska A; Pawłowski M
    Arch Pharm (Weinheim); 2016 Oct; 349(10):774-784. PubMed ID: 27510801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugs.
    Xu M; Wang Y; Yang F; Wu C; Wang Z; Ye B; Jiang X; Zhao Q; Li J; Liu Y; Zhang J; Tian G; He Y; Shen J; Jiang H
    Bioorg Med Chem Lett; 2018 Feb; 28(4):606-611. PubMed ID: 29395980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT
    Gao J; Chen L; Li M
    Pharmacol Biochem Behav; 2019 May; 180():32-43. PubMed ID: 30904543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivalent approaches and beyond: novel tools for the investigation of dopamine D2 receptor pharmacology.
    Kopinathan A; Scammells PJ; Lane JR; Capuano B
    Future Med Chem; 2016 Jul; 8(11):1349-72. PubMed ID: 27357619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative pharmacophore analysis of dual dopamine D2/5-HT(2A) receptor antagonists].
    Guo YS; Guo ZR
    Yao Xue Xue Bao; 2009 Mar; 44(3):314-20. PubMed ID: 19449530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of novel dopamine D
    Zhang C; Li Q; Meng L; Ren Y
    J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 4-nitroindole derivatives as 5-HT2A receptor antagonists.
    Hayat F; Viswanath AN; Pae AN; Rhim H; Park WK; Choo HY
    Bioorg Med Chem; 2015 Mar; 23(6):1313-20. PubMed ID: 25684421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of serotonin 5-HT
    Nie L; Di T; Li Y; Cheng P; Li M; Gao J
    Pharmacol Biochem Behav; 2018 Aug; 171():74-84. PubMed ID: 29944910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic effects of N-desmethylclozapine on sensorimotor gating function in rats--possible involvement of activation of M(1) muscarinic receptors.
    Maehara S; Satow A; Hikichi H; Ohta H
    Eur J Pharmacol; 2011 Sep; 667(1-3):242-9. PubMed ID: 21658379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
    Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
    Huang M; Panos JJ; Kwon S; Oyamada Y; Rajagopal L; Meltzer HY
    J Neurochem; 2014 Mar; 128(6):938-49. PubMed ID: 24164459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimanic potency of typical neuroleptic drugs and affinity for dopamine D2 and serotonin 5-HT2A receptors--a new analysis of data from the archives and implications for improved antimanic treatments.
    Harrison-Read PE
    J Psychopharmacol; 2009 Nov; 23(8):899-907. PubMed ID: 18635692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and preliminary in vitro and in vivo pharmacological evaluation of 2-{4-[4-(2,5-disubstituted thiazol-4-yl)phenylethyl]piperazin-1-yl}-1,8-naphthyridine-3-carbonitriles as atypical antipsychotic agents.
    Gowri Chandra Sekhar KV; Rao VS; Deuther-Conrad W; Reddy AS; Brust P; Krishna Kumar MM
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):561-8. PubMed ID: 21171898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of PDZ ligands as inhibitors of 5-HT(2A) receptor/PSD-95 PDZ1 domain interaction possessing anti-hyperalgesic activity.
    Vogrig A; Dorr L; Bouzidi N; Boucherle B; Wattiez AS; Cassier E; Vallon G; Ripoche I; Abrunhosa-Thomas I; Marin P; Nauton L; Thery V; Courteix C; Lian LY; Ducki S
    ACS Chem Biol; 2013 Oct; 8(10):2209-16. PubMed ID: 23895101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.